Member Login
Sign Up

Qigong in Cancer Care: Theory, Evidence-Base and Practice

Qigong in Cancer Care: Theory, Evidence-Base, and Practice.  

Author: Penelope Klein.

This important research paper can help physicians understand the benefits of qigong for cancer patients and can be used by NQA members to approach cancer care centers about offering a qigong program.  Please help us spread the word about the benefits of qigong for people with cancer.

Download Full Paper Abstract

Background: The purpose of this discussion is to explore the theory, evidence base, and practice of Qigong for individuals with cancer.

Questions addressed are: What is qigong? How does it work? What evidence exists supporting its practice in integrative oncology? What barriers to wide-spread programming access exist?

Methods: Sources for this discussion include a review of scholarly texts, the Internet, PubMed, field observations, and expert opinion.Results: Qigong is a gentle, mind/body exercise integral within Chinese medicine. Theoretical foundations include Chinese medicine energy theory, psychoneuroimmunology, the relaxation response, the meditation effect, and epigenetics. Research supports positive effects on quality of life (QOL), fatigue, immune function and cortisol levels, and cognition for individuals with cancer. There is indirect, scientific evidence suggesting that qigong practice may positively influence cancer prevention and survival. No one Qigong exercise regimen has been established as superior. Effective protocols do have common elements: slow mindful exercise, easy to learn, breath regulation, meditation, emphasis on relaxation, and energy cultivation including mental intent and self-massage.

Conclusions: Regular practice of Qigong exercise therapy has the potential to improve cancer-related QOL and is indirectly linked to cancer prevention and survival. Wide-spread access to quality Qigong in cancer care programming may be challenged by the availability of existing programming and work force capacity.

Source: Medicines2017, 4(1), 2; doi:10.3390/medicines4010002